APA Annual Meeting 2022 On-Demand Package-Buprenorphine Update and Evolving Standards of Care

Video Transcription

Video Summary

Summary:<br /><br />This video features a panel of experts discussing various topics related to opioid use disorder and treatment options. They cover subjects such as epidemiology, regulatory changes, the impact of COVID-19, standards of care, and different medications like Suboxone and Vivitrol. They emphasize individualized treatment and tailoring approaches to each patient's needs. The experts also discuss the use of sublocade, an extended-release buprenorphine injection, and microdosing induction for smoother transitions. The video provides valuable insights into the current state of opioid addiction and the importance of a comprehensive, patient-centered approach to treatment.<br /><br />The video transcript additionally explores the differences in effectiveness between Suboxone and Vivitrol, dosing and frequency of Vivitrol injections, the need for counseling in substance use disorder treatment, and recent studies suggesting the efficacy of brief, frequent physician contact. Managing pain in patients on medication-assisted treatment (MAT), challenges of patient retention, and the benefits of long-term maintenance with methadone or buprenorphine are also mentioned. The transcript concludes by discussing induction methods for naltrexone and the effects of MAT on mortality rates.<br /><br />No specific credits are mentioned in the transcript.<br /><br />---<br /><br />Updated summary (Revised based on word limit and removing repetitive information):<br /><br />The video features a panel of experts discussing opioid use disorder and treatment options. They cover topics like the prevalence of fentanyl, regulatory changes for accessibility, and the use of sublocade and microdosing induction in treatment. The experts stress the need for individualized treatment and tailoring approaches. Additionally, the video transcript discusses the differing effectiveness of Suboxone and Vivitrol, dosing and counseling, brief physician contact, managing pain in MAT, retention challenges, long-term maintenance, induction methods for naltrexone, and the effects of MAT on mortality rates. No specific credits are mentioned.

Keywords

opioid use disorder

treatment options

panel of experts

regulatory changes

Suboxone

Vivitrol

individualized treatment

sublocade

microdosing induction

differences in effectiveness

counseling in substance use disorder treatment

patient retention challenges

long-term maintenance